|
Parameters
|
Survivor
|
Non-survivor
|
Overall population
|
P
|
|---|
|
Number
|
38
|
16
|
54
|
NA
|
|
Age (years)
|
49 (45–56)
|
50 (45–61)
|
49 (45–56)
|
0.458
|
|
Male, n (%)
|
31 (81.6%)
|
12 (75%)
|
43 (79.6%)
|
0.714
|
|
WBC (10^9/L)
|
14.22 (12.43–15.77)
|
14.85 (13.68–17.45)
|
14.23 (13.09–16.44)
|
0.0709
|
|
LC (10^9/L)
|
0.89 (0.75–1.05)
|
0.77 (0.66–0.90)
|
0.86 (0.71–1.03)
|
0.0316
|
|
SOFA score
|
7 (6–9)
|
10 (9–13)
|
8 (6–10)
|
<0.0001
|
|
SAPS II
|
28 (24–34)
|
43 (31–50)
|
31 (25–42)
|
0.0011
|
|
APACHE II score
|
14 (12–16)
|
19 (16–22)
|
15 (13–19)
|
0.0005
|
|
CRP (mg/L)
|
124.5 (101.1–148.3)
|
137.3 (117.4–175.2)
|
126.9 (105.7–157.1)
|
0.076
|
|
IgM (g/L)
|
0.85 (0.78–1.01)
|
0.73 (0.63–0.91)
|
0.84 (0.75–0.95)
|
0.0067
|
|
IL-6 (pg/ml)
|
80 (68–91.08)
|
93.01 (81.01–100.9)
|
83.13 (72.8–94.26)
|
0.0114
|
|
IL-10 (pg/ml)
|
83.72 (70.76–97.9)
|
94.44 (80.86–104.4)
|
87.6 (75.33–100.6)
|
0.1093
|
|
CD100+/CD4+ T cells %
|
66.4 (54.9–75.6)
|
53.9 (46.4–65.5)
|
61.8 (50.1–71.5)
|
0.0174
|
|
CD100+/CD8+ T cells %
|
73.3 (63.1–77.9)
|
54.4 (48.9–69)
|
70.8 (56.2–76.3)
|
0.0003
|
|
CD72+/CD19+ B cells %
|
68.4 (59.1–74.5)
|
54.9 (46–66.4)
|
65.8 (55.6–73.2)
|
0.0018
|
- Data are shown as median (interquartile ranges), frequencies and percentages. The comparisons just performed between survivors and non-survivors, using Student’s t test or Mann-Whitney U test. NA Not applicable, WBC Counts of white blood cell, LC Counts of lymphocyte, SOFA Sequential organ failure assessment, APACHE II Acute physiology and chronic health evaluation II, SAPS II Simplified acute physiology score II, CRP C-reaction protein, IgM Immunoglobulin M, IL interleukin
